๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 36 Shanghai 20 Nanjing 15 Hangzhou 9 Xi'an 8
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
China National Center for Cardiovascular Diseases12 Peking Union Medical College Hospital4 Chinese PLA General Hospital3 Weill Medical College of Cornell University2 Beijing Anzhen Hospital2
Site location
Beijing36 Shanghai20 Nanjing15 Hangzhou9 Xi'an8
All 61 locations
Target enrolment
to

Trials with a site in Beijing

36 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
NCT07762755Coronary Artery Disease, Hyperlipidaemia, Hypertriglyceridaemia, Coronary Atherosclerosis
DrugIcosapent Ethyl
China National Center for Cardiovascular Diseases
Phase 4
100
Beijing
2026-08-01
Not yet open
A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation
NCT07766434Coronary Artery Disease
China National Center for Cardiovascular Diseases
Observational
10,000
Beijing
2026-08
Recruiting
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
NCT07521007Atherosclerosis, Coronary Artery Disease
Beijing Inno Medicine Co., Ltd.
Phase 2
456
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Harbin, Wuhan, Changsha
2026-07-31
Recruiting
Cold-Region Exposure and Cardiac Remodeling After PCI
NCT07773870Coronary Artery Disease, Percutaneous Coronary Intervention (PCI), Left Ventricular Remodeling, Cold Exposure
Chinese PLA General Hospital
Observational
400
Beijing
2026-06-30
Recruiting
QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial
NCT07635407Coronary Artery Disease, Coronary Stenosis, Ischemic Heart Disease
China National Center for Cardiovascular Diseases
Not applicable
1,472
Beijing
2026-06-02
Not yet open
CHIP-CC Registry: A Prospective Multicenter Registry of Complex High-Risk PCI in China
NCT07557238Coronary Artery Disease, High Risk PCI, Percutaneous Coronary Intervention (PCI)
Guofeng Gao
Observational
1,000
Beijing
2026-06-01
Not yet open
Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients
NCT07536607Coronary Artery Disease
Chinese PLA General Hospital
Observational
180
Beijing
2026-04-20
Recruiting
SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
NCT07614230Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease, Atherosclerosis
Junjie Yang
Phase 4
144
Beijing
2026-01-01
Not yet open
Evaluating the Safety and Effectiveness of a Vascular Interventional Robotic System in Assisting With Percutaneous Coronary Intervention Procedures: A Prospective, Multicenter, Randomized Controlled Clinical Trial
NCT07233317Coronary Artery Disease
China National Center for Cardiovascular Diseases
Not applicable
170
Beijing
2025-12-01
Not yet open
pCAD-POAF 3 Year Follow-up
NCT07146061Coronary Artery Disease, Atrial Fibrillation
China National Center for Cardiovascular Diseases
Observational
430
Beijing
2025-08
Recruiting
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
NCT06014060Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent, Dual Antiplatelet Therapy
China National Center for Cardiovascular Diseases
Not applicable
3,300
Beijing
2025-06-20
Recruiting
A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis
NCT07034157Coronary Artery Disease, Carotid Artery Stenosis, Cerebrovascular Disorders
Beijing Anzhen Hospital
Observational
1,000
Beijing
2025-06-09
Recruiting
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
NCT06917664Coronary Artery Disease, Ischemic Mitral Regurgitation, Angiotensin Receptor/Neprilysin Inhibitor
China National Center for Cardiovascular Diseases
Phase 4
220
Beijing
2025-06-05
Not yet open
SONICURE๏ผˆSONICracker for the Treatment of UndeRExpansion๏ผ‰
NCT06924736Coronary Artery Disease
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Not applicable
200
Beijing
2025-05-15
Recruiting
Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study
NCT06845410Coronary Artery Disease, Coronary Artery Disease Progression, Coronary Artery Stenosis, Coronary Artery Restenosis
Peking Union Medical College Hospital
Observational
120
Beijing
2025-04-01
Recruiting
PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study
NCT07822737Coronary Artery Disease, Plaque, Photon-Counting Computed Tomography
Beijing Chao Yang Hospital
Observational
500
Beijing
2025-01-18
Recruiting
Validating a Medical AI Fine-Tuning Platform for Major Diseases
NCT07795645Chronic Gastritis, Gastric Cancer (GC), Coronary Artery Disease, Stroke
Beijing Friendship Hospital
Observational
96,000
Beijing
2024-11-01
Recruiting
Hydration Guided by Remote Dielectric Sensing (ReDS) System for Preventing Acute Kidney Injury in Elderly Patients With Renal Insufficiency for Coronary Angiography and Intervention
NCT07394959Coronary Artery Disease, Chronic Kidney Disease, Elderly
Chinese PLA General Hospital
Not applicable
320
Beijing
2024-09-20
Recruiting
Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules
NCT07773064Coronary Artery Disease
Beijing Hospital
Observational
3,000
Beijing
2024-05-14
Active, closed
FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease
NCT06218485Coronary Artery Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,942
Beijing, Changsha, Chongqing, Ganzhou, Guangdong, Hangzhou, Huzhou, Jinan
2024-03-13
Recruiting
Automated Echocardiographic Detection of Coronary Artery Disease Using Artificial Intelligence Methods
NCT06314295Coronary Artery Disease
Beijing Hospital
Observational
1,500
Beijing
2024-03-11
Recruiting
Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
NCT06489080Acute Myocardial Infarction, Coronary Artery Disease
Peking University First Hospital
Observational
10,000
Beijing
2024-03-01
Recruiting
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
NCT05638867Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome
DrugsRivaroxaban·Clopidogrel·Aspirin
China National Center for Cardiovascular Diseases
Phase 4
3,944
Beijing
2023-11-25
Recruiting
Disease Characteristics of IR-CAD: a Case-control Study
NCT06007248Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis, Coronary Artery Disease Progression
Peking Union Medical College Hospital
Observational
30
Beijing
2023-11-02
Not yet open
Radial Artery Versus No-touch Saphenous Vein
NCT06014047Coronary Artery Disease
China National Center for Cardiovascular Diseases
Not applicable
774
Beijing
2023-11-01
Recruiting
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
NCT05860400Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis, Coronary Artery Disease Progression
Peking Union Medical College Hospital
Observational
39
Beijing
2023-05-17
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Beijing, Changchun, Shanghai, Tianjin
2023-04-17
Active, closed
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
NCT05360446Coronary Artery Disease
DrugInclisiran sodium
Novartis Pharmaceuticals
Phase 3
609
Beijing, Nanjing, Shanghai
2022-07-08
Recruiting
Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease
NCT05337319Coronary Artery Disease
Beijing Anzhen Hospital
Observational
100,000
Beijing
2022-01-17
Active, closed
Imaging Markers of High-Risk Plaque Phenotype for Predicting Post-PCI Outcomes
NCT07117084Coronary Artery Disease, Percutaneous Coronary Intervention (PCI), Atherosclerosis of Coronary Artery
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
2,000
Beijing, Taiโ€™an, Weifang
2021-01-01
Recruiting
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
NCT05437965Coronary Artery Disease, Arteritis, In-Stent Stenosis (Restenosis) of Coronary Artery Stent
China National Center for Cardiovascular Diseases
Observational
1,000
Beijing
2020-06-03
Active, closed
Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease
NCT04397211Coronary Artery Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,872
Hangzhou, Beijing, Guangdong, Huzhou, Jinan, Jinhua, Kunming, Nanchang
2020-05-29
Recruiting
Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass
NCT04220047Coronary Artery Disease, Stroke, Atrial Fibrillation
China National Center for Cardiovascular Diseases
Not applicable
400
Beijing
2020-04-30
Recruiting
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
NCT03378934Coronary Artery Disease, Percutaneous Coronary Intervention
DrugsBerberine·Clopidogrel·Aspirin
Peking Union Medical College Hospital
Phase 4
64
Beijing
2018-09-26
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Beijing, Changchun, Shanghai, Taiwan, Tianjin
2018-01-07
Active, closed
No-Touch Versus Conventional Saphenous Vein Harvesting Technique
NCT03126409Coronary Artery Disease
China National Center for Cardiovascular Diseases
Not applicable
2,655
Beijing
2017-05-14
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

23 of the 36 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 8 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 36 studies
PhaseStudiesRecruitingShare
Observational171247.2%
Not applicable12633.3%
Phase 45413.9%
Phase 2112.8%
Phase 3102.8%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
China National Center for Cardiovascular Diseases126
Peking Union Medical College Hospital44
Chinese PLA General Hospital32
Beijing Anzhen Hospital22
Beijing Hospital22
Second Affiliated Hospital, Zhejiang University, School of Medicine20
Weill Medical College of Cornell University22
Beijing Chao Yang Hospital11
Beijing Friendship Hospital11
Beijing Inno Medicine Co., Ltd.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.